プレマーケットデータ（自動更新なし）20日平均DV $33M?
Earnings 2026-08-1052W high -39.2%52W low +50.8%Fwd PER 54.8xMarket cap $1.2BAvg volume 2.9M
Company Overview
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2026 Q1 | -0.88 | $0 | -$150M |
| 2025 Q4 | -1.21 | $0 | -$131M |
| 2025 Q3 | -1.64 | $0 | -$146M |
| 2025 Q2 | -1.94 | $0 | -$168M |
| 2025 Q1 | -2.17 | $0 | -$166M |
| 2024 Q4 | -1.85 | $0 | -$171M |
| 2024 Q3 |
